Christine A. Carberry

Nessuna posizione attualmente

63 anni

Health Technology

Consumer Services

Profilo

Christine A.
Carberry worked as Vice President-Program & Alliance Management at Biogen, Inc. She then worked as Chief Operating Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2017 to 2018.
Prior to that, she was VP-Technical Operations & Alliance Management at FORUM Pharmaceuticals, Inc. from 2014 to 2016.
Carberry holds a graduate degree from Boston University and an undergraduate degree from the University of New Hampshire.

Precedenti posizioni note di Christine A. Carberry

Società	Posizione	Fine
KERYX BIOPHARMACEUTICALS	Direttore operativo	12/12/2018
FORUM Pharmaceuticals, Inc. FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.	Corporate Officer/Principal	01/05/2016
BIOGEN INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Christine A. Carberry

Formazione di Christine A. Carberry

Boston University	Graduate Degree
University of New Hampshire	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christine A. Carberry

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
BIOGEN INC.	Health Technology

Aziende private	2
FORUM Pharmaceuticals, Inc. FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA.	Health Technology
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.	Health Technology